Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2026)

Neurocrine Biosciences filings provide 7 years of Tax Rate readings, the most recent being 35.8% for Q4 2025.

  • On a quarterly basis, Tax Rate fell 80.0% to 35.8% in Q4 2025 year-over-year; TTM through Dec 2025 was 32.15%, a 238.0% increase, with the full-year FY2025 number at 32.15%, up 238.0% from a year prior.
  • Tax Rate hit 35.8% in Q4 2025 for Neurocrine Biosciences, up from 28.2% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 47.1% in Q4 2021 to a low of 25.8% in Q1 2024.
  • Median Tax Rate over the past 5 years was 28.16% (2023), compared with a mean of 25.96%.
  • Biggest five-year swings in Tax Rate: soared 78139bps in 2021 and later crashed -5164bps in 2024.
  • Neurocrine Biosciences' Tax Rate stood at 47.1% in 2021, then tumbled by -48bps to 24.51% in 2022, then increased by 4bps to 25.48% in 2023, then skyrocketed by 44bps to 36.59% in 2024, then fell by -2bps to 35.8% in 2025.
  • The last three reported values for Tax Rate were 35.8% (Q4 2025), 28.2% (Q3 2025), and 32.6% (Q2 2025) per Business Quant data.